4.0
Feb 10, 2013
Recommend
CEO approval
Business Outlook
Pros
the company had good benefits and competitive salaries, assignments allowed opportunities for further growth. For its size, the company had a decent revenue stream. good place to start your career and to learn
Cons
the company had its ups and downs the most recent one from losing a key product in Vytorin due to a small clinical trial. CEO Fred Hassan ended-up selling the company at the great bottom of the financial crisis to another behemoth company.